Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Versant Venture Capital VI, L.P. reported a 3.40% stake in Monte Rosa Therapeutics, Inc. (Schedule 13D/A)

Event Jan 7, 2026 · Filed Jan 9, 2026

Versant Venture Capital VI, L.P. reported a 3.40% stake in Monte Rosa Therapeutics, Inc., 2,236,708 shares, with active intent on Jan 7, 2026. Filed Jan 9, 2026 (Schedule 13D/A).

Stake
3.40%
Shares
2,236,708
Intent
Active
What changed
Stake changed
Filed together
6 holders

The filing in full

HolderStakeShares
Versant Venture Capital VI, L.P.3.40%2,236,708
Versant Ventures VI GP, L.P.3.40%2,236,708
Versant Ventures VI GP-GP, LLC3.40%2,236,708
Versant Vantage I, L.P.1.60%1,013,361
Versant Vantage I GP, L.P.1.60%1,013,361
Versant Vantage I GP-GP, LLC1.60%1,013,361

Source

View original at SEC

Related